Sign in Subscribe
HIV infections

US Announces Significant Investment in Global HIV/AIDS Fight with "Game-Changing" Drug

Strategic Insights

— 1 min read

The US State Department is making a significant investment in the global battle to stop the spread of AIDS, announcing it will work with a pharmaceutical company and the global fund to procure a new HIV prevention drug dubbed a "game-changer." This new drug, lenacapavir, has shown almost complete protection against HIV in clinical trials, and its approval in the US has sparked excitement in the medical community.

Key Takeaways:

  • The US State Department will work with Gilead, the manufacturer of lenacapavir, and the global fund to get the medication to countries with the highest HIV burden, with a focus on pregnant and breastfeeding mothers.
  • The aim is to reach up to 2 million people in the next three years, with a priority on countries in Africa where the HIV/AIDS epidemic takes the biggest toll.
  • The US is aiming to make the medication available without profit, with the price tag being done at cost.
  • This announcement comes in contrast to the Trump administration's cuts to foreign aid programs, including HIV prevention efforts, with over $4 billion in cuts announced this year.
  • The US approach is seen as a shift towards purchasing commodities like drugs that are medical breakthroughs and made in the US, rather than relying on NGOs and international organizations.

Statistics:

  • 2 million people expected to be reached in the next three years in countries with the highest HIV burden.
  • 80-90% protection against HIV shown by lenacapavir in clinical trials.
  • $4 billion in foreign aid cuts announced by the Trump administration this year, including HIV prevention efforts.
  • 67% of the global HIV/AIDS burden is concentrated in Africa, where the new medication will be prioritized.

Sources:

  • NPR's Gabrielle Emanuel, interview with State Department officials.
  • "Clinical trials of lenacapavir finds almost complete protection against HIV" - The Lancet, 2023.
  • "US announces investment in global HIV/AIDS fight with 'game-changing' drug" - NPR, 2023.
  • "Linda-Gail Bekker, University of Cape Town" - quote from University of Cape Town press release, date not specified.

Read more